These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18752589)

  • 21. Chronic lymphocytic leukaemia Is terminal del(14)(q24) a new marker for prognostic stratification?
    La Starza R; Barba G; Matteucci C; Crescenzi B; Romoli S; Pierini V; Beacci D; Cantaffa R; Martelli MF; Mecucci C
    Leuk Res; 2006 Dec; 30(12):1569-72. PubMed ID: 16650893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lenalidomide can be highly effective in chronic lymphocytic leukaemia despite T-cell depletion and deletion of chromosome 17p.
    Arumainathan A; Kalakonda N; Pettitt AR
    Eur J Haematol; 2011 Oct; 87(4):372-5. PubMed ID: 21679253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia.
    Durak B; Akay OM; Aslan V; Ozdemir M; Sahin F; Artan S; Gülbas Z
    Cancer Genet Cytogenet; 2009 Jan; 188(2):65-9. PubMed ID: 19100507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations.
    Blanco G; Puiggros A; Baliakas P; Athanasiadou A; García-Malo M; Collado R; Xochelli A; Rodríguez-Rivera M; Ortega M; Calasanz MJ; Luño E; Vargas M; Grau J; Martínez-Laperche C; Valiente A; Cervera J; Anagnostopoulos A; Gimeno E; Abella E; Stalika E; Hernández-Rivas JM; Ortuño FJ; Robles D; Ferrer A; Ivars D; González M; Bosch F; Abrisqueta P; Stamatopoulos K; Espinet B
    Oncotarget; 2016 Dec; 7(49):80916-80924. PubMed ID: 27821812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma.
    Stöcklein H; Smardova J; Macak J; Katzenberger T; Höller S; Wessendorf S; Hutter G; Dreyling M; Haralambieva E; Mäder U; Müller-Hermelink HK; Rosenwald A; Ott G; Kalla J
    Oncogene; 2008 Apr; 27(18):2613-25. PubMed ID: 17982487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosomal imbalances in familial chronic lymphocytic leukaemia: a comparative genomic hybridisation analysis.
    Summersgill B; Thornton P; Atkinson S; Matutes E; Shipley J; Catovsky D; Houlston RS; Yuille MR
    Leukemia; 2002 Jul; 16(7):1229-32. PubMed ID: 12094247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profile and genomic changes in disease progression of early-stage chronic lymphocytic leukemia.
    Fernàndez V; Jares P; Salaverria I; Giné E; Beà S; Aymerich M; Colomer D; Villamor N; Bosch F; Montserrat E; Campo E
    Haematologica; 2008 Jan; 93(1):132-6. PubMed ID: 18166798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
    Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
    Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation.
    Dijkstra MK; van Lom K; Tielemans D; Elstrodt F; Langerak AW; van 't Veer MB; Jongen-Lavrencic M
    Leukemia; 2009 Mar; 23(3):625-7. PubMed ID: 18818704
    [No Abstract]   [Full Text] [Related]  

  • 30. Biallelic deletion 13q14.3 in patients with chronic lymphocytic leukemia: cytogenetic, FISH and clinical studies.
    Chena C; Avalos JS; Bezares RF; Arrossagaray G; Turdó K; Bistmans A; Slavutsky I
    Eur J Haematol; 2008 Aug; 81(2):94-9. PubMed ID: 18462257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic data in prognostic models-what is lost in translation? The case of deletion 17p and mutant TP53 in chronic lymphocytic leukaemia.
    Chin-Yee B; Sadikovic B; Chin-Yee IH
    Br J Haematol; 2020 Mar; 188(5):652-660. PubMed ID: 30836431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA repair polymorphisms associated with cytogenetic subgroups in B-cell chronic lymphocytic leukemia.
    Ganster C; Neesen J; Zehetmayer S; Jäger U; Esterbauer H; Mannhalter C; Kluge B; Fonatsch C
    Genes Chromosomes Cancer; 2009 Sep; 48(9):760-7. PubMed ID: 19484764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic stem cell transplant in patients with chronic lymphocytic leukemia with 17p deletion: consult-transplant versus consult- no-transplant analysis.
    Poon ML; Fox PS; Samuels BI; O'Brien S; Jabbour E; Hsu Y; Gulbis A; Korbling M; Champlin R; Abruzzo LV; Bassett RL; Khouri IF
    Leuk Lymphoma; 2015 Mar; 56(3):711-5. PubMed ID: 24913509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NICE guidance on ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia in the presence of 17p deletion or TP53 mutation.
    Mikudina B; Goodall M; Adler AI
    Lancet Oncol; 2017 Mar; 18(3):289-290. PubMed ID: 28130034
    [No Abstract]   [Full Text] [Related]  

  • 35. 17p deletion in chronic lymphocytic leukemia: risk stratification and therapeutic approach.
    Schnaiter A; Stilgenbauer S
    Hematol Oncol Clin North Am; 2013 Apr; 27(2):289-301. PubMed ID: 23561474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of chromosomal abnormalities associated with chronic lymphocytic leukemia: what is the best method?
    El-Taweel M; Barin C; Cymbalista F; Eclache V
    Cancer Genet Cytogenet; 2009 Nov; 195(1):37-42. PubMed ID: 19837267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion: report from the Polish Adult Leukemia Group.
    Robak T; Blonski JZ; Wawrzyniak E; Gora-Tybor J; Palacz A; Dmoszynska A; Konopka L; Warzocha K; Jamroziak K
    Cancer; 2009 Jan; 115(1):94-100. PubMed ID: 19025975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors.
    Rossi D; Sozzi E; Puma A; De Paoli L; Rasi S; Spina V; Gozzetti A; Tassi M; Cencini E; Raspadori D; Pinto V; Bertoni F; Gattei V; Lauria F; Gaidano G; Forconi F
    Br J Haematol; 2009 Jun; 146(1):64-75. PubMed ID: 19438485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays.
    Pfeifer D; Pantic M; Skatulla I; Rawluk J; Kreutz C; Martens UM; Fisch P; Timmer J; Veelken H
    Blood; 2007 Feb; 109(3):1202-10. PubMed ID: 17053054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia.
    Brown JR; Hanna M; Tesar B; Werner L; Pochet N; Asara JM; Wang YE; Dal Cin P; Fernandes SM; Thompson C; Macconaill L; Wu CJ; Van de Peer Y; Correll M; Regev A; Neuberg D; Freedman AS
    Clin Cancer Res; 2012 Jul; 18(14):3791-802. PubMed ID: 22623730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.